Evidence map›Paper›PMID 42593672›Full record

ArticleArchives of microbiology2026

Burkholderia arboris bacteremia initially identified as Burkholderia cepacia complex: a genome-based case report.

Kazuhiro Itoh, Amane Tanaka, Daiki Maruno, Hiroshi Tsutani, Nozomi Otsuki, Atsushi Kuwata, Chiyo Kiriba, Yoshimasa Urasaki, Masamichi Ikawa, Hiromichi Iwasaki and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kazuhiro ItohDepartment of Community Health Science, Faculty of Medical Sciences, University of Fukui, Fukui, Japan. kitoh@u-fukui.ac.jp.ORCID http://orcid.org/0000-0001-5574-7118
Amane TanakaDepartment of Internal Medicine, NHO Awara National Hospital, 238-1 Kitagata, Awara, 910-4272, Fukui, Japan.
Daiki MarunoDepartment of Laboratory Medicine, NHO Awara National Hospital, Awara, Japan.
Hiroshi TsutaniDepartment of Internal Medicine, NHO Awara National Hospital, 238-1 Kitagata, Awara, 910-4272, Fukui, Japan.
Nozomi OtsukiDepartment of Internal Medicine, NHO Awara National Hospital, 238-1 Kitagata, Awara, 910-4272, Fukui, Japan.
Atsushi KuwataDepartment of Internal Medicine, NHO Awara National Hospital, 238-1 Kitagata, Awara, 910-4272, Fukui, Japan.
Chiyo KiribaDepartment of Internal Medicine, NHO Awara National Hospital, 238-1 Kitagata, Awara, 910-4272, Fukui, Japan.
Yoshimasa UrasakiDepartment of Internal Medicine, NHO Awara National Hospital, 238-1 Kitagata, Awara, 910-4272, Fukui, Japan.
Masamichi IkawaDepartment of Community Health Science, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Hiromichi IwasakiDepartment of Community Health Science, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Yasuhiko MitsukeDepartment of Internal Medicine, NHO Awara National Hospital, 238-1 Kitagata, Awara, 910-4272, Fukui, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a bloodstream Burkholderia arboris isolate from a 75-year-old man without cystic fibrosis. The organism was recovered from both aerobic bottles of two separately collected blood-culture sets and was initially assigned to the Burkholderia cepacia complex (Bcc) by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. Whole-genome sequencing yielded three circular chromosomes and one circular plasmid. DFAST_QC identified B. arboris as the only type-strain match above the species threshold, with an average nucleotide identity of 99.48%; the next-highest match was B. seminalis at 93.33%. Multilocus sequence typing identified ST-2575, and ResFinder detected no acquired antimicrobial resistance genes. The patient improved after 14 days of meropenem therapy without recurrent B. arboris bacteremia. This report adds a clinically supported bloodstream infection, a complete genome resource, and detailed susceptibility data, while illustrating the importance of up-to-date reference genomes for species-level interpretation of unusual Bcc isolates.

Indexed as

BacteremiaBurkholderiaBurkholderia cepacia complexBurkholderia InfectionsGenome, BacterialAgedAnti-Bacterial AgentsHumansMaleMeropenemMicrobial Sensitivity TestsMultilocus Sequence TypingSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationThienamycinsWhole Genome SequencingAnti-Bacterial AgentsMeropenemThienamycinsAntimicrobial susceptibility testingAverage nucleotide identityBacteremiaBurkholderia cepacia complexMALDI-TOF MSWhole-genome sequencing

Identifiers

PMID42593672
PMCPMC13473173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.